Endo Pharmaceuticals (C): An At Risk Launch Harvard Case Solution & Analysis

No abstract is available for this product.
This case is only available in paper format (HBP do not have the rights to distribute digital content). As a result, a digital copy of an educator if not available through this Web site.
Additives (A) case. "Hide
by Richard G. Hamermesh, Brian J. Delacey Source: Harvard Business School 13 pages. Publication Date: January 30, 2006. Prod. #: 806066-HCB-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.